Disease/Infection News

RSS
Researchers report first evidence of Seoul hantavirus in wild rats in the Netherlands

Researchers report first evidence of Seoul hantavirus in wild rats in the Netherlands

Changes in moles and skin cancer: an interview with Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson

Changes in moles and skin cancer: an interview with Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson

Climate change causes emergence of more infectious diseases

Climate change causes emergence of more infectious diseases

Experience with Ebola outbreak highlights local responses to global health threats

Experience with Ebola outbreak highlights local responses to global health threats

Consortium formed to develop program to improve health outcomes for Ebola patients

Consortium formed to develop program to improve health outcomes for Ebola patients

Door-to-door campaing encourages people to get tested for hepatitis C and to get linked to care

Door-to-door campaing encourages people to get tested for hepatitis C and to get linked to care

Study: Ebola transmission from deceased patients may be possible

Study: Ebola transmission from deceased patients may be possible

New antibody shows promise in increasing survival for patients suffering from influenza, pneumonia

New antibody shows promise in increasing survival for patients suffering from influenza, pneumonia

Risk of ovarian cancer increased with even short-term HRT use

Risk of ovarian cancer increased with even short-term HRT use

Immune system exploits flu virus' dependence on host's machinery

Immune system exploits flu virus' dependence on host's machinery

Lenvatinib trial offers hope for thyroid cancer patients

Lenvatinib trial offers hope for thyroid cancer patients

'Mad Cow' discovery points to possible neuron killing mechanism behind alzheimer’s and parkinson’s diseases

'Mad Cow' discovery points to possible neuron killing mechanism behind alzheimer’s and parkinson’s diseases

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

Elusys presents positive results of obiltoxaximab for treating inhalational anthrax, post-exposure prophylaxis

New study indicates that malaria-causing parasite is unlikely to cross from animals to humans

New study indicates that malaria-causing parasite is unlikely to cross from animals to humans

Research provides new insights into rapid defence responses in human immune system

Research provides new insights into rapid defence responses in human immune system

Researchers develop novel approach to identify potential antimalarial drugs

Researchers develop novel approach to identify potential antimalarial drugs

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

Health Canada: Parents advised not to feed honey to infants less than one year old

Health Canada: Parents advised not to feed honey to infants less than one year old

AbbVie submits NDA in Japan for investigational, all-oral treatment of patients with chronic HCV infection

AbbVie submits NDA in Japan for investigational, all-oral treatment of patients with chronic HCV infection

Standard cleaning procedures in retail delis may not eradicate Listeria pathogen, study shows

Standard cleaning procedures in retail delis may not eradicate Listeria pathogen, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.